DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20203749

A study on safety and efficacy of intralesional vitamin D3 in cutaneous warts

Amruthavalli Potlapati, Narendra Gangaiah, Neethu Mary George

Abstract


Background: Immunotherapy is an upcoming treatment modality for cutaneous warts. Majority of the treatment modalities used for warts are destructive and can be painful, causes scarring and are not suitable for multiple warts. Immunotherapy overcome these shortcomings and it has shown good response both in injected and distant warts. Literature shows only very limited data on the use of immunotherapy, especially vitamin D3, in case of cutaneous warts. Objective was to evaluate the safety and efficacy of intralesional vitamin D3 in cutaneous warts and to assess the treatment response and adverse effects of the same.

Methods: Sixty patients of age more than 18 years of both sexes with cutaneous warts were given intralesional vitamin D3 of maximum five doses two weeks apart after obtaining an informed written consent. Patients were monitored for reduction in size and number of warts and also for any side effects.

Results: Out of the total 60 patients, 46 (76.6%) patients had complete resolution of warts following injection, 12 (20%) cases showed partial response and 2 (3.4%) cases had no response.

Conclusions: Intralesional vitamin D3 was found to be an effective treatment modality for multiple and recalcitrant warts.


Keywords


Warts, Immunotherapy, Vitamin D3, Intralesional injection, Verrucae

Full Text:

PDF

References


Aktaş H, Ergin C, Demir B, Ekiz Ö. Intralesional Vitamin D Injection May Be an Effective Treatment Option for Warts. J Cutan Med Surg. 2016; 20(2):118‐122.

Manjunath K. Safety and efficacy of intralesional vitamin D3 in cutaneous warts: An open uncontrolled trial. Journal of Cutaneous and Aesthetic Surgery. 2017;10(2): 90.

Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol. 2011;77:261-3.

Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016;7:364-70.

Gibbs S. The trials of treating warts. Indian J Dermatol Venereol Leprol. 2014;80:495-6.

Podder I, Bhattacharya S, Mishra V, Sarkar TK, Chandra S, Sil A et al. Immunotherapy in viral warts with intradermal Bacillus Calmette–Guerin vaccine versus intradermal tuberculin purified protein derivative: A double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India. Indian J Dermatol Venereol Leprol. 2017;83:41.

Saoji V, Lade NR, Gadegone R, Bhat A. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial. Indian J Dermatol Venereol Leprol. 2016;82(1):42‐46.

Sinha S, Relhan V, Garg VK. Immunomodulators in warts: Unexplored or ineffective? Indian J Dermatol. 2015;60(2):118‐129.

Raghukumar S, Ravikumar BC, Vinay KN, Suresh MR, Aggarwal A, Yashovardhana DP. Intralesional Vitamin D3 Injection in the Treatment of Recalcitrant Warts: A Novel Proposition. J Cutan Med Surg. 2017;21(4):320‐324.

Singh SK, Mohan A, Gupta AK, Pandey AK. A comparative study between intralesional PPD and vitamin D3 in treatment of viral warts. Int J Res Dermatol. 2018;4:197-201.

Banoth S. Evaluation of therapeutic effectiveness of vitamin D3 injections in common warts in a tertiary care centre. Int J Res Dermatol. 2019;5:462-5.

Kareem, IMA, Ibrahim, IM, Mohammed, SFF, Ahmed, AA‐B. Effectiveness of intralesional vitamin D3 injection in the treatment of common warts: Single‐blinded placebo‐controlled study. Dermatologic Therapy. 2019;32:e12882.